The yin/yang aspect of NRF2 signaling was first elaborated by Wang et al., reporting that knockdown of NRF2 using siRNA, or stable overexpression of KEAP1, sensitized human cancer cells to chemotherapy [7]. This evidence concerns the gene KEAP1 and cancer.